BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25194727)

  • 1. Validation of a nomogram in the prediction of local recurrence risks after conserving surgery for Asian women with ductal carcinoma in situ of the breast.
    Wang F; Li H; Tan PH; Chua ET; Yeo RM; Lim FL; Kim SW; Tan DY; Wong FY
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):684-91. PubMed ID: 25194727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram.
    Sweldens C; Peeters S; van Limbergen E; Janssen H; Laenen A; Patil S; Van Zee KJ; Weltens C
    Cancer J; 2014; 20(1):1-7. PubMed ID: 24445756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
    Yi M; Meric-Bernstam F; Kuerer HM; Mittendorf EA; Bedrosian I; Lucci A; Hwang RF; Crow JR; Luo S; Hunt KK
    J Clin Oncol; 2012 Feb; 30(6):600-7. PubMed ID: 22253459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study.
    Collins LC; Achacoso N; Haque R; Nekhlyudov L; Quesenberry CP; Schnitt SJ; Habel LA; Fletcher SW
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S502-8. PubMed ID: 26059650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of low-risk ductal carcinoma in situ in Southeast Asian women treated with breast conservation therapy.
    Wong FY; Wang F; Chen JJ; Tan CH; Tan PH
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):998-1003. PubMed ID: 24661651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
    Mechera R; Viehl CT; Oertli D
    Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Rudloff U; Brogi E; Brockway JP; Goldberg JI; Cranor M; Wynveen CA; Nehhozina T; Reiner AS; Patil S; Van Zee KJ
    Cancer; 2009 Mar; 115(6):1203-14. PubMed ID: 19170233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
    Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
    Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term impact of young age at diagnosis on treatment outcome and patterns of failure in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Vicini FA; Shaitelman S; Wilkinson JB; Shah C; Ye H; Kestin LL; Goldstein NS; Chen PY; Martinez AA
    Breast J; 2013; 19(4):365-73. PubMed ID: 23815268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Web-Based IBTR! 2.0 Nomogram to Predict for Ipsilateral Breast Tumor Recurrence After Breast-Conserving Therapy.
    Kindts I; Laenen A; Peeters S; Janssen H; Depuydt T; Nevelsteen I; Van Limbergen E; Weltens C
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1477-1484. PubMed ID: 27315662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipsilateral tumor recurrence risk in women with ductal carcinoma in situ: application of the Van Nuys Prognostic Index and the Memorial Sloan Kettering Cancer Center nomogram.
    Hashiba KA; Bahl M
    Breast Cancer Res Treat; 2023 Nov; 202(1):185-190. PubMed ID: 37518825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making.
    Pleijhuis RG; Kwast AB; Jansen L; de Vries J; Lanting R; Bart J; Wiggers T; van Dam GM; Siesling S
    Breast; 2013 Oct; 22(5):773-9. PubMed ID: 23462681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a Novel Nomogram for Prediction of Local Relapse after Surgery for Invasive Breast Carcinoma.
    Corso G; Maisonneuve P; Massari G; Invento A; Pravettoni G; De Scalzi A; Intra M; Galimberti V; Morigi C; Lauretta M; Sacchini V; Veronesi P
    Ann Surg Oncol; 2020 Jun; 27(6):1864-1874. PubMed ID: 31965372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-year outcomes after breast-conserving surgery and definitive radiotherapy for mammographically detected ductal carcinoma in situ.
    Wilkinson JB; Vicini FA; Shah C; Shaitelman S; Jawad MS; Ye H; Kestin LL; Goldstein NS; Martinez AA; Benitez P; Chen PY
    Ann Surg Oncol; 2012 Nov; 19(12):3785-91. PubMed ID: 22644510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast.
    Lee SK; Yang JH; Woo SY; Lee JE; Nam SJ
    Br J Surg; 2013 Dec; 100(13):1756-63. PubMed ID: 24227361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
    Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
    Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Including the Ductal Carcinoma-In-Situ (DCIS) Score in the Development of a Multivariable Prediction Model for Recurrence After Excision of DCIS.
    Paszat L; Sutradhar R; Zhou L; Nofech-Mozes S; Rakovitch E
    Clin Breast Cancer; 2019 Feb; 19(1):35-46. PubMed ID: 30190195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
    Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
    Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.